Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 22, 689-695, July 1, 1962]
© 1962 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ollodart, R.
Right arrow Articles by Rose, N. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ollodart, R.
Right arrow Articles by Rose, N. R.

Antibodies to 1,2-Naphthoquinone*

Robert Ollodart{dagger} and Noel R. Rose

( Departments of Bacteriology and Immunology, and of Surgery, University of Buffalo, Buffalo, N.Y.)

We have prepared an antibody against 1,2-naphthoquinone. This was accomplished by conjugating the quinone to bovine gamma-globulin. The conjugation product showed a visible light absorption peak of 445 mµ. The globulin-quinone antigen was used to produce rabbit antibodies shown to be specific for 1,2-naphthoquinone. The antibodies could be demonstrated by tanned cell hemagglutination and by passive cutaneous anaphylaxis. Quinone conjugated to human serum served as antigen in the former test. In passive cutaneous anaphylaxis, the quinone itself provoked the reaction. However, experimental evidence suggests an in vivo conjugation of the compound with guinea pig serum. The extent of cross-reaction with related naphthoquinone derivatives could be determined quantitatively by inhibition of hemagglutination. The possible value of this type of serological reagent for studying the process of carcinogenesis is discussed.

* Supported in part by P.H.S. research grant C-5203 from the National Cancer Institute, National Institutes of Health, Public Health Service.

{dagger} Postdoctoral Research Fellow of the American Cancer Society. At present, Resident in Surgery, Buffalo General Hospital.

Received 11/ 2/61.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1962 by the American Association for Cancer Research.